article thumbnail

Study offers insights on why the elderly are more susceptible to COVID-19

The Pharma Data

” The findings not only answer important questions about key mechanisms of the complex SARS-CoV-2 virus, Elias said, but also have direct implications for the development of therapeutics to control the viral infection. “This means there will be less infection in the presence of this therapeutic FRG antibody.”

article thumbnail

Clinical Data From Full Phase 1 Cohort Of Investigational Sotorasib Published In New England Journal Of Medicine

The Pharma Data

executive vice president of Research and Development at Amgen. executive vice president of Research and Development at?Amgen, Amgen’s clinical development team and clinical investigators, will discuss Phase 1 data being presented on the Company’s investigational KRAS G12C ?inhibitor Reese , M.D., Sunday, Sept.